Clinical Trial Update: Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation

View source ↗

Summary

A Hannover Medical School trial update exploring proteomics to detect acute cellular rejection in lung transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Rejection

Snippet

Sponsor: Hannover Medical School | Conditions: Rejection, Lung Transplantation | Status: UNKNOWN